奇正藏药2025年净利6.46亿元，同比增长10.98%

Core Viewpoint - Qizheng Tibetan Medicine (002287) reported its 2025 performance, showing a revenue of 2.416 billion yuan, representing a year-on-year growth of 3.34%, and a net profit attributable to shareholders of 646 million yuan, reflecting a year-on-year increase of 10.98% [1] Financial Performance - The company achieved an operating income of 2.416 billion yuan in 2025, which is a 3.34% increase compared to the previous year [1] - The net profit attributable to shareholders reached 646 million yuan, marking a 10.98% growth year-on-year [1]